PT-141 (3mg x 10 Vials = 30mg) Certificate

PT 141 Peptide is a revolutionary sexual wellness therapy designed to enhance libido and arousal in both men and women. Unlike traditional ED medications, PT 141 works directly through the nervous system to stimulate desire and improve sexual response. Commonly used to treat low libido, sexual dysfunction, and boost overall intimacy, it offers a safe, non-hormonal solution with fast-acting results. PT 141 is available in injectable and nasal spray forms, making it a convenient option for individuals seeking a natural way to reignite passion and improve sexual satisfaction.

 

 

PT-141 (Bremelanotide) is a melanocortin receptor agonist peptide that works by stimulating areas of the brain responsible for sexual arousal and desire. Unlike conventional treatments for sexual dysfunction that focus on blood flow (such as PDE-5 inhibitors like sildenafil), PT-141 addresses the neurological pathways involved in libido.

Originally derived from Melanotan II, PT-141 was refined to focus on sexual function without significant tanning effects. Clinical research has demonstrated its effectiveness in supporting both men with erectile dysfunction (ED) and women with hypoactive sexual desire disorder (HSDD).

Key Benefits:

• Enhances sexual desire and arousal in both men and women
• Works through central nervous system pathways (not just vascular)
• May be effective when other treatments (like PDE-5 inhibitors) are ineffective
• Fast onset of action after administration
• Potential mood and confidence enhancement in intimate settings

Uses (Research/Clinical):

• Treatment of female sexual dysfunction (FDA-approved for premenopausal women under the brand name Vyleesi®)
• Support for male erectile dysfunction, especially in cases unresponsive to traditional treatments
• Research into sexual motivation and neurological regulation of desire

Dosage (Research/Clinical Guidelines):

• Administration: Subcutaneous injection
• Typical Range: 1–2 mg, used on-demand prior to anticipated sexual activity
• Note: Dosage may vary depending on clinical guidance; use only under proper supervision.

PT-141 (bremelanotide) is a synthetic peptide that works by activating melanocortin receptors in the central nervous system.¹ This unique mechanism of action targets the root cause of sexual dysfunction by increasing sexual desire and arousal.² Unlike traditional treatments that focus on blood flow, PT-141 works on the brain, making it effective for both men and women.³

Key benefits of PT-141 include:

Increased sexual desire: Enhances libido and motivation for sexual activity.⁴

Improved arousal:⁵ Boosts natural arousal and response to sexual stimuli.⁶

Effective for both sexes: A powerful solution for both male erectile dysfunction and female sexual arousal disorder.⁷

Unique mechanism of action: Targets the central nervous system for a more natural and complete response.⁸

Convenient administration: Typically administered via subcutaneous injection or nasal spray for ease of use.⁹

PT-141 offers a groundbreaking alternative for individuals seeking to revitalize their sexual health and intimacy.¹⁰

Bremelanotide

Bremelanotide, also known as PT-141, is a synthetic peptide drug developed to treat sexual dysfunction in both men and women. It is a melanocortin receptor agonist that works by activating melanocortin receptors in the central nervous system.¹ This action leads to a natural increase in sexual desire and arousal.

Unlike other treatments for sexual dysfunction that primarily focus on blood flow, bremelanotide’s mechanism is unique because it acts on the brain to stimulate sexual response. It is a powerful solution for addressing the psychological and neurological aspects of low libido and arousal.

Bremelanotide is typically administered as a subcutaneous injection or a nasal spray. It has been approved by the FDA under the brand name Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.²

Key features of Bremelanotide:

Targeted Action: Works on the brain’s melanocortin pathways to increase sexual desire.³

Dual-Sex Efficacy: Effective for treating sexual dysfunction in both men and women.⁴

FDA-Approved: Vyleesi, the brand name for bremelanotide, is a recognized treatment for HSDD.⁵

Non-Hormonal: Does not rely on hormonal changes to achieve its effects.

Convenient Administration: Available in easy-to-use forms like injections and nasal sprays.

Bremelanotide represents a significant advancement in the treatment of sexual dysfunction, offering a unique and effective way to enhance intimacy and sexual well-being

PT-141 (Bremelanotide) FAQ

Q1: What is PT-141?
PT-141, also known as Bremelanotide, is a synthetic peptide developed to treat sexual dysfunction. Unlike other treatments that act on the vascular system (like PDE5 inhibitors), PT-141 works directly on the nervous system by stimulating melanocortin receptors in the brain to enhance sexual desire and arousal.

Q2: What is PT-141 used for?
PT-141 is primarily used to address:

• Hypoactive sexual desire disorder (HSDD) in women
• Erectile dysfunction (ED) in men (particularly when standard treatments don’t work)
• General enhancement of sexual desire and libido

Q3: How is PT-141 administered?
PT-141 is typically given as a subcutaneous injection (under the skin) about 45 minutes to 1 hour before anticipated sexual activity. Some formulations (such as intranasal sprays) exist but are less common.

Q4: How does PT-141 work differently from Viagra or Cialis?
Viagra (sildenafil) and Cialis (tadalafil) increase blood flow to the genitals by targeting PDE5 enzymes. PT-141 instead activates melanocortin receptors in the brain, which trigger sexual arousal and desire, not just physical readiness.

Q5: How long does PT-141 last?
Effects typically begin within 30–60 minutes and can last 6 to 12 hours, though some individuals may experience benefits for up to 24–36 hours.

Q6: What are the possible side effects of PT-141?
Reported side effects include:

• Nausea (most common)
• Flushing or warmth in the face
• Headache
• Increased blood pressure
• Injection site reactions

Most side effects are temporary and dose-dependent.

Q7: Is PT-141 FDA-approved?
Yes. PT-141 (under the brand name Vyleesi) is FDA-approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. However, its use in men is considered off-label.

Q8: Who should avoid using PT-141?

• People with uncontrolled high blood pressure or cardiovascular conditions
• Those with a history of severe side effects to melanocortin-based peptides
• Pregnant or breastfeeding women

Always consult a healthcare provider before use.

Q9: Can PT-141 be combined with other ED medications?
Some people combine PT-141 with PDE5 inhibitors (like Viagra) for stronger effects, but this should only be done under medical supervision, as both can affect blood pressure and overall circulation.

Q10: How can I get PT-141?
In the U.S., PT-141 is available by prescription only under the brand name Vyleesi for women. Compounding pharmacies may provide PT-141 for men, though this is an off-label use. Online vendors exist, but sourcing outside regulated pharmacies carries safety and legality risks.